1844
M. Drag et al. / Tetrahedron: Asymmetry 14 (2003) 1837–1845
(s), 156.17 (s). 31P NMR: l=25.87 (1R,2S), 26.41
(1S,2S); ESI=325.8, 347.9 (M+Na)+.
62.10 (s), 66.97 (d, 1J(C,P)=167.8 Hz). 31P NMR:
l=24.29 (1R,2S,3S), 25.11 (1S,2S,3S); ESI=226.
4.4.3. Dimethyl (1S,2S,3S)/(1R,2S,3S)-(2-tert-butoxy-
carbonyloamino-1-hydroxy-3-methyl)pentylphosphonate
(83/17 mixture), 3c. 82% yield, IR: w=1044, 1176, 1250,
1367, 1506, 1714, 2875, 2958, 3329 cm1. 1H NMR
(CDCl3): l=0.90 (m, 6H, 2×CH3), 1.13 (m, 1H, CH)
1.42 (s, 9H, Boc), 1.5 (m, 2H, CH2), 3.54 (m, 1H, CH),
4.6. General procedure for the synthesis of (1S,2S)-2-
amino-1-hydroxyalkylphosphonates 5
The dimethyl (2-amino-1-hydroxy)alkylphosphonate
hydrochloride 4 was refluxed in 50 ml of 8 M HCl for
8–10 h. After evaporation of the volatile products in
vacuo, the residue was dissolved in 100 ml of ethanol
and treated with propylene oxide (pH=6). The precipi-
tated acid was filtered off and recrystallized 3–5 times
from water to give pure syn diastereomer of 5. In the
case of 5c the final product was obtained by the recrys-
tallisation from water and isopropanol.
3
3.80 (d, 6H, J(H,P)=10.6 Hz, 2×OCH3), 3.84 (m, 1H,
3
CH), 5.60 (d, 1H, J(H,H)=8.2 Hz, NH). 13C NMR
(CDCl3): l=11.12 (s), 15.64 (s), 25.40 (s), 28.33 (s),
35.85 (d, 3J(C,P)=11.8 Hz), 53.16 (d, 2J(C,P)=7.4 Hz),
53.75 (d, 2J(C,P)=7.0 Hz), 55.24 (s), 67.64 (d,
1J(C,P)=163.1 Hz), 79.17 (s), 156.34 (s). 31P NMR:
l=25.41 (1R,2S,3S), 26.02 (1S,2S,3S); ESI=325.8,
347.6 (M+Na)+.
4.6.1. (1S,2S)-(2-Amino-1-hydroxy)propyl phosphonic
acid, 5a. 72% yield, mp=247–250°C, [h]2D6.7=+19.3 (c 1,
water), IR: w=916, 1040, 1096, 1143, 1509, 1628, 2361,
4.5. General procedure for the synthesis of dimethyl
(2-amino-1-hydroxy)alkylphosphonates hydrochlorides 4
1
3
3154 cm−1. H NMR (D2O): l=1.28 (d, 3H, J(H,H)=
3
6.6 Hz, CH3), 3.47 (ddq, 1H, J(H,H)=5.3 Hz, 6.6 Hz,
3
The
dimethyl
(2-tert-butoxycarbonyloamino-1-
2J(H,P)=5.8 Hz, CH), 3.60 (dd, 1H, J(H,H)=5.3 Hz,
hydroxy)alkylphosphonate 3 was stirred in 6 M hydro-
gen chloride saturated in methanol for 30 min. The
solvent was removed under reduced pressure, and the
residue treated with diethyl ether (20 ml). Evaporation
of this solvent on rotary evaporator gave compound 4
in quantitative yield as white semisolid.
3J(H,P)=8.9, CH). 13C NMR (D2O): l=15.4 (d,
3J(C,P)=8.7 Hz), 49.02 (s), 68.41 (d, 1J(C,P)=156.2
Hz). 31P NMR (D2O): l=17.27. Anal. calcd for
C3H10NO4P: C, 23.23; H, 6.45; N, 9.03. Found: C,
23.21; H, 6.08; N, 8.77%.
4.6.2.
(1S,2S)-(2-Amino-1-hydroxy-4-methyl)pentyl
4.5.1. Dimethyl (1S,2S)/(1R,2S)-(2-amino-1-hydroxy)-
propylphosphonate hydrochloride (81/19 mixture), 4a.
IR: w=1051, 1185, 1242, 1370, 1507, 1611, 2959, 3329
phosphonic acid, 5b. 78% yield, mp=235.5–238.5°C,
[h]2D5.9=+8.7 (c 1, water), IR: w=937, 1015, 1076, 1134,
1526, 1618, 2881, 3145 cm−1. H NMR (D2O): l=0.84
1
1
3
3
cm−1. H NMR (CD3OD): l=1.43 (d, 3H, J(H,H)=
6.7 Hz, CH3), 3.74 (m, 1H, CH), 3.82 (d, 6H, 3J(P,H)=
10.6 Hz, 2×OCH3), 3.92 (m, 1H, CH), 8.08 (bs, 4H,
(d, 6H, J(H,H)=7.0 Hz, 2×CH3), 1.42 (m, 1H, CH),
1.57 (m, 2H, CH2), 3.50 (m, 1H, CH), 3.71 (dd, 1H,
3J(H,H)=2.2 Hz, J(H,P)=10.5 Hz, CH). 13C NMR
3
OH, NH3 ) 13C NMR (CD3OD): l=15.10 (d,
(D2O): l=21.38 (s), 23.56 (s), 38.18 (d, J(C,P)=9.6
+
3
1J(C,P)=9.8 Hz), 52.37 (d, J(C,P)=6.2 Hz), 54.05 (d,
Hz), 57.37 (s), 65.83 (d, J(C,P)=155.4 Hz). 31P NMR
2
1
2
2J(C,P)=7.4 Hz), 54.48 (d, J(C,P)=7.5 Hz), 66.73 (d,
(D2O): l=17.57. Anal. calcd for C6H16NO4P: C, 36.52;
H, 8.11; N, 7.10. Found: C, 36.43; H, 7.89; N, 6.88%.
1J(C,P)=167.1 Hz). 31P NMR (CD3OD): l=23.73
(1R,2S), 24.56 (1S,2S); ESI=184.0.
4.6.3. (1S,2S,3S)-(2-Amino-1-hydroxy-3-methyl)pentyl
phosphonic acid, 5c. 66% yield, mp=216–220°C.
[h]2D8.3=+8.2 (c 1, water), IR: w=942, 1013, 1080, 1134
4.5.2. Dimethyl (1S,2S)/(1R,2S)-(2-amino-1-hydroxy-4-
methyl)pentylphosphonate hydrochloride (88/12 mixture),
1
1
4b. IR: w=1050, 1216, 1470, 1506, 1608, 2960 cm−1. H
1528, 1616, 2881, 3145 cm−1. H NMR (D2O): l=0.76
3
3
3
NMR (CDCl3): l=0.98 (d, 6H, J(H,H)=5.0 Hz, 2×
(t, 3H, J(H,H)=7.3 Hz, CH3), 0.83 (d, 3H, J(H,H)=
6.7 Hz, CH3), 1.05 (m, 1H, CH), 1.60 (m, 2H, CH2),
3.12 (m, 1H, CH), 3.86 (dd, 1H, 3J(H,H)=2.0 Hz,
3J(H,P)=11.3 Hz, CH). 13C NMR (D2O): l=9.82 (s),
CH3), 1.57 (m, 2H, CH2), 1.74 (m, 1H, CH), 3.82 (2d,
3
6H, J(H,P)=10.5 Hz, 2×OCH3), 4.02 (m, 2H, 2×CH),
6.10 (bs, 4H, NH3 , OH). 13C NMR (CDCl3): l=22.65
+
3
(s), 24.26 (s), 38.02 (d, 3J(C,P)=4.9 Hz), 53.61 (d,
14.19 (s), 24.22 (s), 33.86 (d, J(C,P)=10.1 Hz), 56.40
2J(C,P)=7.0 Hz), 54.76 (d, J(C,P)=7.0 Hz), 65.75 (d,
(s), 63.92 (d, 1J(C,P)=155.1 Hz). 31P NMR (D2O):
l=17.10. Anal. calcd for C6H16NO4P: C, 36.52; H,
8.11; N, 7.10. Found: C, 36.52; H, 8.13; N, 6.77%.
2
1J(C,P)=166.6 Hz). 31P NMR: l=24.77 (1R,2S), 24.93
(1S,2S); ESI=225.6.
4.5.3. Dimethyl (1S,2S,3S)/(1R,2S,3S)-(2-amino-1-
hydroxy-3-methyl)pentylphosphonate hydrochloride (83/
17 mixture), 4c. IR: w=1050, 1216, 1371, 1471, 1508,
4.7. Synthesis of Boc-(S)-Phe-(S)-Ala-PO3Me2, 6
Boc-(S)-phenylalanine (5 mmol) was dissolved in 10 ml
of dry THF and 12 mmol of N-methylmorpholine was
added dropwise to the mixture. The mixture was then
cooled in an ice–water bath to −20°C and 5.5 mmol of
isobutyl chloroformate was added. After 1 h, 5 mmol of
(1S,2S)/(1R,2S) dimethyl (2-amino-1-hydroxy)propyl-
phosphonate hydrochloride 3a was added and the mix-
ture was stirred overnight at room temperature. THF
1
1610, 2961 cm−1. H NMR (CDCl3): l=1.12 (m, 6H,
2×CH3), 1.22 (m, 1H, CH), 1.59 (m, 2H, CH2), 3.76 (m,
3
1H, CH), 3.81 (d, 3H, J(H,P)=10.3 Hz, OCH3), 3.86
3
(d, 3H, J(H,P)=10.5 Hz, OCH3), 4.02 (m, 1H, CH),
6.11 (bs, 4H, NH3 , OH). 13C NMR (CDCl3): l=12.82
+
(s), 18.36 (s), 24.02 (s), 35.27 (d, 3J(C,P)=4.2 Hz),
2
2
52.57 (d, J(C,P)=7.0 Hz), 53.08 (d, J(C,P)=7.0 Hz),